VERALLIA | Finanzwire

Basculer en Français

9472	Companies
185370	Keywords
117721	Articles
99262	Press releases

Home
Companies
VERALLIA

BRIEF

published on 04/25/2025 at 17:50, 7 months 9 days ago

Verallia Shareholders Approve Key Resolutions at Annual Meeting

Dividend Approval 2024 Financials Verallia AGM Board Renewals BM&A Auditor
PRESS RELEASE

published on 04/25/2025 at 17:45, 7 months 9 days ago

Inside Information / Other news releases
Verallia's General Shareholders' Meeting 2025 approves financial statements, dividend payout and board member renewals. Detailed results available on website

Financial Statements Dividend Payout General Shareholders' Meeting Verallia Board Member Renewals
BRIEF

published on 04/24/2025 at 08:55, 7 months 10 days ago

BWGI Initiates Tender Offer for Verallia

AMF Tender Offer Financial Strategy Verallia BWGI
PRESS RELEASE

published on 04/24/2025 at 08:50, 7 months 10 days ago

News releases during takeover bids / Takeover bids Other news releases
BWGI initiates tender offer for Verallia at price of 30 euros per share, with lenders consultation. Verallia takes steps to maintain financings, including consent solicitation for bondholders and backstop credit agreement

Bondholders Tender Offer Financial Verallia BWGI
BRIEF

published on 03/27/2025 at 17:50, 8 months 8 days ago

Verallia makes the 2024 Universal Registration Document available

Sustainability AMF Registration Document Verallia 2024 Financial Report
PRESS RELEASE

published on 03/27/2025 at 17:45, 8 months 8 days ago

Inside Information / Other news releases
Verallia releases its 2024 Universal Registration Document filing with the AMF in ESEF format. Document accessible on Verallia's and AMF's websites, containing financial and governance reports as well as sustainability information

Sustainability AMF ESEF Format Verallia 2024 Universal Registration Document
PRESS RELEASE

published on 02/19/2025 at 18:45, 9 months 13 days ago

Inside Information / News release on accounts, results
BRIEF

published on 10/22/2024 at 18:55, 1 year 1 month ago

Verallia Reports Q3 2024 Results Amid Market Challenges

Market Challenges Revenue Decline Decarbonization Efforts Q3 2024 Results Debt And Acquisition
PRESS RELEASE

published on 10/22/2024 at 18:50, 1 year 1 month ago

Inside Information / News release on accounts, results
Verallia returns to moderate organic volume growth in 2024 Q3 despite challenging market, with adjusted EBITDA expected to be on par with 2022. Inaugurates 100% electric furnace in Cognac for sector's decarbonization

Decarbonization Adjusted EBITDA Verallia Organic Volume Growth Electric Furnace
BRIEF

published on 07/23/2024 at 10:57, 1 year 4 months ago

Threshold crossing for VERALLIA

Voting Rights Amundi Asset Management Crossing Threshold FCPE Verallia Fusion-absorption

Accesswire

Published on 12/05/2025 at 02:35, 4 hours 41 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 4 hours 46 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 6 hours 16 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 8 hours 11 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 8 hours 16 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 07:00, 15 minutes ago

Swiss Re targets a net income of USD 4.5 billion in 2026; refreshed strategy to strengthen core business
Published on 12/05/2025 at 03:30, 3 hours 45 minutes ago

CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 7 hours 25 minutes ago

EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 10 hours 50 minutes ago

Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 11 hours 1 minute ago

Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025

Les Echos

Published on 12/04/2025 at 18:00, 13 hours 16 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 13 hours 31 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 13 hours 31 minutes ago

Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day ago

bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 13 hours ago

Declaration of voting rights at the end of November 2025

View all LES ECHOS COMFI WIRE